Our findings suggest that inflammatory biomarkers and widely available biomarkers as BNP/NT-proBNP and hsTnT should be used for the screening of cardiac alterations in patients with RA and asymptomatic individuals. Here, NPPB is linked to rheumatoid arthritis.